245 related articles for article (PubMed ID: 32858470)
1. Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment.
Maslah H; Skarbek C; Pethe S; Labruère R
Eur J Med Chem; 2020 Dec; 207():112670. PubMed ID: 32858470
[TBL] [Abstract][Full Text] [Related]
2. ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.
Peng X; Gandhi V
Ther Deliv; 2012 Jul; 3(7):823-33. PubMed ID: 22900465
[TBL] [Abstract][Full Text] [Related]
3. Boronic acid/boronate prodrugs for cancer treatment: current status and perspectives.
Maslah H; Pethe S; Labruère R
Future Med Chem; 2021 May; 13(10):859-861. PubMed ID: 33845596
[No Abstract] [Full Text] [Related]
4. Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs.
Daum S; Reshetnikov MSV; Sisa M; Dumych T; Lootsik MD; Bilyy R; Bila E; Janko C; Alexiou C; Herrmann M; Sellner L; Mokhir A
Angew Chem Int Ed Engl; 2017 Dec; 56(49):15545-15549. PubMed ID: 28994179
[TBL] [Abstract][Full Text] [Related]
5. A dithiocarbamate-based H
Pan Q; Zhang B; Peng X; Wan S; Luo K; Gao W; Pu Y; He B
Chem Commun (Camb); 2019 Nov; 55(92):13896-13899. PubMed ID: 31675022
[TBL] [Abstract][Full Text] [Related]
6. Dual Stimuli-Activatable Oxidative Stress Amplifying Agent as a Hybrid Anticancer Prodrug.
Han E; Kwon B; Yoo D; Kang C; Khang G; Lee D
Bioconjug Chem; 2017 Apr; 28(4):968-978. PubMed ID: 28192990
[TBL] [Abstract][Full Text] [Related]
7. Photoactivation of Boronic Acid Prodrugs via a Phenyl Radical Mechanism: Iridium(III) Anticancer Complex as an Example.
Liu M; Luo Y; Yan J; Xiong X; Xing X; Kim JS; Zou T
J Am Chem Soc; 2023 May; 145(18):10082-10091. PubMed ID: 37098902
[TBL] [Abstract][Full Text] [Related]
8. Strategies on the development of small molecule anticancer drugs for targeted therapy.
Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
[TBL] [Abstract][Full Text] [Related]
9.
Reshetnikov V; Özkan HG; Daum S; Janko C; Alexiou C; Sauer C; Heinrich MR; Mokhir A
Molecules; 2020 May; 25(11):. PubMed ID: 32486084
[TBL] [Abstract][Full Text] [Related]
10. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.
Yao H; Chen S; Deng Z; Tse MK; Matsuda Y; Zhu G
Inorg Chem; 2020 Aug; 59(16):11823-11833. PubMed ID: 32799491
[TBL] [Abstract][Full Text] [Related]
11. Aminoferrocene-based prodrugs activated by reactive oxygen species.
Hagen H; Marzenell P; Jentzsch E; Wenz F; Veldwijk MR; Mokhir A
J Med Chem; 2012 Jan; 55(2):924-34. PubMed ID: 22185340
[TBL] [Abstract][Full Text] [Related]
12. Highly Stable Silica-Coated Bismuth Nanoparticles Deliver Tumor Microenvironment-Responsive Prodrugs to Enhance Tumor-Specific Photoradiotherapy.
Xiang H; Wu Y; Zhu X; She M; An Q; Zhou R; Xu P; Zhao F; Yan L; Zhao Y
J Am Chem Soc; 2021 Aug; 143(30):11449-11461. PubMed ID: 34292717
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells.
McGoldrick CA; Jiang YL; Brannon M; Krishnan K; Stone WL
BMC Cancer; 2014 Sep; 14():675. PubMed ID: 25234292
[TBL] [Abstract][Full Text] [Related]
14. Delivery of a system x
Xin H; Huang Y; Tang H; Chen Y; Xia H; Zhang F; Li B; Ping Y
J Mater Chem B; 2021 Sep; 9(35):7172-7181. PubMed ID: 34369535
[TBL] [Abstract][Full Text] [Related]
15. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
16. Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with
Daum S; Toms J; Reshetnikov V; Özkan HG; Hampel F; Maschauer S; Hakimioun A; Beierlein F; Sellner L; Schmitt M; Prante O; Mokhir A
Bioconjug Chem; 2019 Apr; 30(4):1077-1086. PubMed ID: 30768258
[TBL] [Abstract][Full Text] [Related]
17. Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death.
Noh J; Kwon B; Han E; Park M; Yang W; Cho W; Yoo W; Khang G; Lee D
Nat Commun; 2015 Apr; 6():6907. PubMed ID: 25892552
[TBL] [Abstract][Full Text] [Related]
18. β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update.
Tranoy-Opalinski I; Legigan T; Barat R; Clarhaut J; Thomas M; Renoux B; Papot S
Eur J Med Chem; 2014 Mar; 74():302-13. PubMed ID: 24480360
[TBL] [Abstract][Full Text] [Related]
19. A Smart Theranostic Prodrug System Activated by Reactive Oxygen Species for Regional Chemotherapy of Metastatic Cancer.
Liu L; Liu F; Liu D; Yuan W; Zhang M; Wei P; Yi T
Angew Chem Int Ed Engl; 2022 Mar; 61(12):e202116807. PubMed ID: 35068033
[TBL] [Abstract][Full Text] [Related]
20. Duocarmycin-based prodrugs for cancer prodrug monotherapy.
Tietze LF; Schuster HJ; Schmuck K; Schuberth I; Alves F
Bioorg Med Chem; 2008 Jun; 16(12):6312-8. PubMed ID: 18524605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
